It downregulates the ligands for NKG2D, UL16 binding protein 2 (ULBP2), and MHC-I related chain A (MICA), on the surface of cancer cells leading to obstructed recognition by NK cells [120] (Figure 1A,B). Here, KLRK1 is linked to cancer.